Table 1.

Tumor characteristics and treatment history (CRS = cytoreductive surgery, HIPEC = hyperthermic intraperitoneal chemotherapy, EPIC = early postoperative intraperitoneal chemotherapy).

Patient No.	Age at initial surgery	Initial surgery with morcellation	Pathology	Interval from morcellation to the time of cytoreductive surgery	Indication for reoperative surgery	Surgery prior to CRS plus HIPEC and EPIC	Chemotherapy prior to HIPEC plus CRS
1	46	Supracervical hysterectomy with morcellation	Leiomyosarcoma	28 days	Staging	None	None
2	40	Laparoscopic hysterectomy with morcellation	Leiomyosarcoma	64 days	Staging	None	None
3	59	Robotic-assisted vaginal hysterectomy with morcellation	Leiomyosarcoma	8 months	Staging	Diagnostic laparoscopy	1) Gemcitabine/Paclitaxel, 2) Doxorubicin/Ifosfamide/Mesna
4	44	Laparoscopic supracervical hysterectomy with morcellation	Leiomyosarcoma	26 months	Recurrence	Ex-lap, trachelectomy, BSO	1) Gemcitabine/Docetaxel, 2) Ifosamide
5	43	Laparoscopic hysterectomy with morcellation	Leiomyomatosis peritonealis	7 years	Recurrence	1) Diagnostic laparoscopy, laparoscopic myomectomy, 2) CT guided biopsy	None
6	57	Hysterectomy with morcellation	Leiomyosarcoma	5 years	Recurrence	debulking surgery	Systemic chemotherapy (detail unknown)